{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T04:04:09Z","timestamp":1774497849784,"version":"3.50.1"},"reference-count":17,"publisher":"BMJ","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMJ Case Reports"],"published-print":{"date-parts":[[2010]]},"abstract":"<jats:p>A 55-year-old Filipina with Grave's disease, diabetes, hypertension, bronchial asthma, Parkinson's disease and a history of adverse drug reaction to penicillin consulted due to high-grade fever and sore throat. Patient was diagnosed with aplastic anaemia secondary to methimazole and was treated with high-dose granulocyte colony stimulating factor, thrombopoietin and mesterolone. Antibiotics used included levofloxacin, clindamycin, amikacin and fluconazole. Due to bleeding and slow recovery of blood parameters, 30 units of platelets and 7 units of packed red blood cells were transfused during her 22-day admission. This case presents a life-threatening adverse drug reaction in a patient with co-morbid conditions that complicate recovery and limit one's therapeutic options.<\/jats:p>","DOI":"10.1136\/bcr.05.2010.2993","type":"journal-article","created":{"date-parts":[[2010,12,21]],"date-time":"2010-12-21T11:08:01Z","timestamp":1292929681000},"page":"bcr0520102993","source":"Crossref","is-referenced-by-count":4,"title":["Successful treatment of methimazole-induced severe aplastic anaemia in a diabetic patient with other co-morbidities"],"prefix":"10.1136","volume":"2010","author":[{"given":"Cindy V","family":"Josol","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myrna","family":"Buenaluz-Sedurante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark Anthony","family":"Sandoval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerry","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2010,12,21]]},"reference":[{"key":"2025042509033703000_2010.dec17_1.bcr0520102993.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra042972"},{"key":"2025042509033703000_2010.dec17_1.bcr0520102993.2","doi-asserted-by":"publisher","DOI":"10.1089\/105072504323150787"},{"key":"2025042509033703000_2010.dec17_1.bcr0520102993.3","unstructured":"Young NS . Aplastic Anemia, Myelodysplasia, and Related Bone Marrow Failure Syndromes. In: Kasper DL Braunwald E Fauci AS Hauser SL Longo DL Jameson JL , eds. Harrison's Principles of Internal Medicine. Sixteenth edition New York, NY: McGraw-Hill 2005:617\u00e2\u0080\u009326."},{"key":"2025042509033703000_2010.dec17_1.bcr0520102993.4","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2008.0097"},{"key":"2025042509033703000_2010.dec17_1.bcr0520102993.5","doi-asserted-by":"publisher","DOI":"10.1089\/105072504773297911"},{"key":"2025042509033703000_2010.dec17_1.bcr0520102993.6","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.1127"},{"key":"2025042509033703000_2010.dec17_1.bcr0520102993.7","first-page":"470","article-title":"Methimazole-induced aplastic anemia","volume":"90","author":"Mechelli","year":"1999","journal-title":"Recenti Prog Med"},{"key":"2025042509033703000_2010.dec17_1.bcr0520102993.8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.297.6643.262"},{"key":"2025042509033703000_2010.dec17_1.bcr0520102993.9","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-199103000-00008"},{"key":"2025042509033703000_2010.dec17_1.bcr0520102993.10","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/92.8.455"},{"key":"2025042509033703000_2010.dec17_1.bcr0520102993.11","first-page":"412","article-title":"Aplastic anemia secondary to methimazole-case report and review of hematologic side effects","volume":"30","author":"Edell","year":"1975","journal-title":"J Am Med Womens Assoc"},{"key":"2025042509033703000_2010.dec17_1.bcr0520102993.12","doi-asserted-by":"publisher","DOI":"10.1089\/thy.1998.8.791"},{"key":"2025042509033703000_2010.dec17_1.bcr0520102993.13","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/BF03349180","article-title":"Successful treatment of methimazole-induced severe aplastic anemia with recombinant human G-CSF and high dose steroids","volume":"29","author":"Jakucs","year":"2006","journal-title":"J Endocrinol Invest"},{"key":"2025042509033703000_2010.dec17_1.bcr0520102993.14","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000206873","article-title":"Transient methimazole-induced bone marrow aplasia:in vitro evidence for a humoral mechanism of bone marrow suppression","volume":"69","author":"Moreb","year":"1983","journal-title":"Acta Haematol"},{"key":"2025042509033703000_2010.dec17_1.bcr0520102993.15","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(98)70185-X"},{"key":"2025042509033703000_2010.dec17_1.bcr0520102993.16","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.8.7.1021"},{"key":"2025042509033703000_2010.dec17_1.bcr0520102993.17","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8652(199802)57:2<113::AID-AJH4>3.0.CO;2-Z"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr.05.2010.2993","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T16:03:45Z","timestamp":1745597025000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr.05.2010.2993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":17,"alternative-id":["10.1136\/bcr.05.2010.2993"],"URL":"https:\/\/doi.org\/10.1136\/bcr.05.2010.2993","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010]]}}}